Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Colorcon
Merck
Johnson and Johnson
Mallinckrodt

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Patent: 8,735,551

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,735,551
Title:Antibodies for epidermal growth factor receptor 3 (HER3)
Abstract: The present invention relates to antibodies or fragments thereof that target a conformational epitope of a HER receptor. In particular, the invention relates to antibodies or fragments thereof that target a conformational epitope of HER3 receptor and compositions and methods of use thereof.
Inventor(s): Garner; Andrew Paul (Cambridge, MA), Sprague; Elizabeth Anne Reisinger (Cambridge, MA), Ettenberg; Seth Alexander (Cambridge, MA), Kunz; Christian (Munich, DE), Haubst; Nicole (Munich, DE), Elis; Winfried (Munchen-Pasing, DE)
Assignee: Novartis AG (Basel, CH)
Application Number:13/214,413
Patent Claims:see list of patent claims

Details for Patent 8,735,551

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc HERCEPTIN HYLECTA trastuzumab; hyaluronidase-oysk INJECTABLE;SUBCUTANEOUS 761106 001 2019-02-28   Start Trial Novartis AG (Basel, CH) 2039-02-26 RX search
Genentech PERJETA pertuzumab VIAL; SINGLE-USE 125409 001 2012-06-08   Start Trial Novartis AG (Basel, CH) 2039-02-26 RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Start Trial Novartis AG (Basel, CH) 2039-02-26 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 8,735,551

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2012022814 Feb 23, 2012
United States of America 10077317 Sep 18, 2018
United States of America 2012107306 May 03, 2012
United States of America 2017166653 Jun 15, 2017
United States of America 2019194347 Jun 27, 2019
Ukraine 114883 Aug 28, 2017
Tunisia 2013000040 Jun 25, 2014
>Country >Patent Number >Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Dow
Medtronic
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.